Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QJ04AD<br />
QJ04AK<br />
QJ04AM<br />
Thiocarbamide derivatives<br />
Other drugs for treatment of tuberculosis<br />
Combinations of drugs for treatment of tuberculosis<br />
QJ04B<br />
QJ04BA<br />
DRUGS FOR THE TREATMENT OF LEPRA<br />
Drugs for treatment of lepra<br />
QJ05<br />
ANTIVIRALS FOR SYSTEMIC USE<br />
This group comprises specific antiviral agents, excl. vaccines.<br />
Antivirals for dermatological use, see QD06BB.<br />
Antivirals for ophtalmological use, see QS01A - Antiinfectives.<br />
Combinations with vitamins are allowed.<br />
QJ05A<br />
DIRECT ACTING ANTIVIRALS<br />
This group comprises agents acting directly on the virus.<br />
QJ05AA<br />
QJ05AB<br />
Thiosemicarbazones<br />
Nucleosides and nucleotides excl. reverse transcriptase inhibitors<br />
The combinations of ribavirin and peginterferon alfa-2a or peginterferon alfa-2b are<br />
classified in QL03AB.<br />
QJ05AC<br />
Cyclic amines<br />
Amantadine is classified in N04 - Anti-parkinson drugs.<br />
QJ05AD<br />
QJ05AE<br />
Phosphonic acid derivatives<br />
Protease inhibitors<br />
Ritonavir added as a pharmacokinetic enhancer is allowed in QJ05AE06 lopinavir.<br />
QJ05AF<br />
QJ05AG<br />
Nucleoside and nucleotide reverse transcriptase inhibitors<br />
Non-nucleoside reverse transcriptase inhibitors<br />
123
Change language